Madrigal Pharmaceuticals, Inc.
(Borse Berlin : SNTA)

( )
SNTA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
4.32%20.5514.1%$354.61m
SAGESAGE Therapeutics, Inc.
-2.40%163.3310.9%$242.63m
SHPGShire PLC Sponsored ADR
0.34%148.500.4%$164.05m
MNKMallinckrodt Plc
3.81%23.1518.5%$83.12m
PRGOPerrigo Co. Plc
-0.09%85.526.6%$83.08m
JAZZJazz Pharmaceuticals Plc
0.74%140.002.2%$52.91m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.68%122.557.6%$52.70m
UTHRUnited Therapeutics Corporation
-0.44%135.6114.5%$49.94m
ICPTIntercept Pharmaceuticals, Inc.
-0.55%61.3422.0%$38.59m
RVNCRevance Therapeutics, Inc.
3.75%35.9514.1%$38.45m
ENDPEndo International Plc
2.93%7.728.9%$35.88m
ADMSAdamas Pharmaceuticals, Inc.
-2.96%35.4716.9%$34.57m
PCRXPacira Pharmaceuticals, Inc.
-1.34%44.2010.7%$34.22m
PTLAPortola Pharmaceuticals, Inc.
-2.34%51.787.8%$32.70m
MDCOMedicines Company
-0.80%26.0022.1%$32.51m

Company Profile

Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA.